Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,713-2,724 of 10,592
Drug study icon
CompletedNCT01143090

Subjects Switched to Lurasidone for schizophrenia

This study is completed in the United States. It is testing subjects Switched to Lurasidone for schizophrenia.

In United States
SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00111189

Effectiveness of efficacy (Effectiveness) of Paliperidone Palmitate in schizophrenia

This study is completed in the United States, in Costa Rica, in Mexico, .... It is testing efficacy (Effectiveness) of Paliperidone Palmitate for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Costa Rica, Mexico, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
Active Not RecruitingNCT06254612

SP-624 for depression

This study is active but not recruiting in the United States. It is testing SP-624 for depression.

In United States
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sirtsei Pharmaceuticals, Inc.
Condition
Depression
Drug study icon
CompletedNCT04115319

Safety study of investigational Drug in schizophrenia

This study is completed in the United States, in Romania, in Russia, .... It is testing investigational Drug for schizophrenia.

Remote / online
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Romania, Russia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00132678

Safety study of safety and Efficacy of Injectable Risperidone in Bipolarity

This study is completed in the United States, in Austria, in India, .... It is testing safety and Efficacy of Injectable Risperidone for Bipolarity.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Austria, India, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.